DCF — NEWTON MEDICAL CENTER
Enterprise Value: $-120.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-120.2M
Enterprise Value
$-38.7M
PV of Cash Flows
$-81.5M
PV of Terminal Value
$-131.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $96.0M | $-7.1M | -7.0% | $-11.2M | $-10.2M |
| Year 2 | $98.9M | $-6.3M | -6.0% | $-10.5M | $-8.7M |
| Year 3 | $101.8M | $-5.5M | -5.0% | $-9.8M | $-7.4M |
| Year 4 | $104.9M | $-5.1M | -5.0% | $-9.6M | $-6.5M |
| Year 5 | $108.0M | $-5.0M | -5.0% | $-9.6M | $-6.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-120.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$93.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.07901759007431951
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5